ASPARKAM AVEXIMA

Registration number:ЛСР-005781/10
International non-proprietary name:potassium aspartate and magnesium aspartate
Pharmaceutical form:tablets
Pharmacotherapeutic group:potassium and magnesium preparation
Dosage form:tablets No. 56
Composition:active substance: magnesium asparaginate tetrahydrate - 175 mg, potasssium asparaginate tetrahydrate - 175 mg

ASPARCAM AVEXIMA is a source of potassium and magnesium ions, it regulates metabolic processes.

ASPARCAM AVEXIMA eliminates electrolyte imbalance, reduces myocardial excitability and conduction (moderate antiarrhythmic effect).

Indications for use:

Combination therapy:

chronic cardiac failure;
ischemic heart disease;
hypokalemia;
heart rhythm disorders (including those in myocardial infarction, overdose with cardiac glycosides).

Method of administration and posology:

for oral administration, after meal.

For adults:: 1-2 tablets 3 times daily.
Course duration is 3-4 weeks.
If required, the course is repeated.
Shelf life:: 3 years. Do not use after the expiry date.
Manufacturer: OJSC "Irbitsky Chemical-Pharmaceutical Plant"

THERE ARE CONTRAINDICATIONS. READ THE INSTRUCTION OR CONSULT A MEDICAL SPECIALIST BEFORE USE